Speakers

< Back To List
Young Saing Kim
  • Professor, Gil Medical Center, Gachon University College of Medicine, South Korea
Balancing the Benefits and Risks of Adjuvant Therapy Across Different Cancer Types
Role Speaker
Date & Time 05/02 14:20 - 15:00
Room 701A
Education / Training
2004, M.D., Gachon University College of Medicine, Incheon, South Korea
2009, M.S., Gachon University Graduate School, Incheon, South Korea
2017, PhD., Gachon University Graduate School, Incheon, South Korea
Professional and Research Experience
2005 - 2009, Residency, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
2012 - 2013, Fellowship, Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
2015 - Present, Professor, Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
2021 - 2022, Visiting Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
Awards & Honors
2008 Young Investigator Travel Award, Korean Society of Medical Oncology (KSMO)
2018 Best Poster Award, ESMO Asia 2018 Congress
2025 Outstanding Paper Award, Korean Cancer Study Group (KCSG)
Selected Publications
  • Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-06)
  • A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities.
  • Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
  • The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.
  • Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.